For Healthcare Professionals: Colorectal Cancer

At Memorial Sloan Kettering we treat more than 2,500 people annually for primary and recurrent colon, rectal, and anal cancer, and have expertise in a range of associated conditions, including appendiceal malignancies, intestinal carcinoid tumors, abdominal desmoid tumors, peritoneal surface malignancies, and rare sacral and retroperitoneal tumors. We also treat Crohn’s disease, ulcerative colitis, perianal Paget’s disease, and various benign anorectal conditions. 

Referring a Patient

Call 866-316-8529
Mon–Fri, 8:30 AM–5:30 PM, ET

Find an Expert | See Clinical Trials | Request a Pathology Consult

More Science. Less Fear.
It’s Time to Change How the World Treats Cancer.

Learn how we’re making what was impossible yesterday possible today.

Prediction Tools

Use our online nomogram to calculate risk of cancer recurrence following surgery for colon cancer. Results can help physicians and patients make important treatment decisions.

Pictured: Moshe Shike & Josephine Abat
Screening Guidelines

Colorectal cancer is the second most common cause of cancer death among men and woman in the United States. Routine screening of symptom-free men and women will lead to a reduction in the number of colorectal cancer cases and deaths.

Pictured: Karen Schupak & Ephraim Casper
Colorectal Cancer Information for Your Patients 

The Memorial Sloan Kettering approach to diagnosis and treatment of colorectal cancer in patient-friendly language.

E-Publications for Medical Professionals

Stay up-to-date on Memorial Sloan Kettering advances in your areas of interest.

Subscribe to OncoNotes »

Pictured: Garrett Nash
Hyperthermic Intraperitoneal Chemotherapy for Cancers of the Appendix, Colon, or Rectum

Memorial Sloan Kettering surgeons describe a phase II trial comparing agents administered through HIPEC for cancers of the appendix, colon, and rectum.

Pictured: Leonard Saltz
Grand Rounds Presentation on Curing Rectal Cancer

Gastrointestinal Oncology Service Chief Leonard Saltz talks about advances in the personalized treatment and cure of rectal cancer in this Grand Rounds presentation.

Pictured: Nancy Kemeny
Treating Liver Metastases with Hepatic Arterial Infusion Therapy

Medical oncologist Nancy Kemeny reviews evidence for HAI in extending survival and improving quality of life for patients with colorectal cancer and liver metastases.

Pictured: Garrett Nash
Colorectal HIPEC
Pictured: Leonard Saltz
Rectal Cancer
Pictured: Nancy Kemeny
Hepatic Arterial Infusion